|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 | (2013.01) |
| C07C 69/34 | (2006.01) | ||
| A61K 31/047 | (2006.01) | ||
| C12Q2600/106 | (2013.01) | ||
| A61K 31/336 | (2006.01) | ||
| C12Q2600/154 | (2013.01) | ||
| A61K 31/495 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C12Q2600/158 | (2013.01) | ||
| A61K 31/495 | (2013.01) | ||
| A61K 31/047 | (2013.01) | ||
| A61N2005/1098 | (2013.01) | ||
| A61K 47/542 | (2017.08) | ||
| A61K 47/593 | (2017.08) | ||
| A61K 47/62 | (2017.08) | ||
| A61K 45/06 | (2013.01) | ||
| A61N 5/10 | (2013.01) | ||
| A61K 31/336 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 2804602 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13738207.3 |
| Date of filing the European patent application | 2013-01-22 | |
| (97) | Date of publication of the European application | 2014-11-26 |
| (45) | Date of publication and mention of the grant of the patent | 2024-12-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/022505 |
| Date | 2013-01-22 |
| (87) | Number | WO 2013/110058 |
| Date | 2013-07-25 |
| (30) | Number | Date | Country code |
| 201261589029 P | 2012-01-20 | US |
| (72) |
BROWN, Dennis , US
BACHA, Jeffrey , CA
DUNN, Sandra , CA
|
| (73) |
Del Mar Pharmaceuticals ,
Suite 115-887 Great Northern Way, Vancouver,
CA
|
| (54) | USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTFORME AND MEDULLOBLASTOMA |
| USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTFORME AND MEDULLOBLASTOMA |